New technique shields healthy liver during cancer radiation

NCT ID NCT06229080

First seen Feb 13, 2026 · Last updated May 16, 2026 · Updated 10 times

Summary

This study tested a method to protect healthy parts of the liver during a radiation treatment called Y90 radioembolization for liver cancer. Doctors used temporary gelatin sponge particles to block blood flow to healthy liver areas, aiming to keep radiation away from them. The study involved 20 adults with primary or metastatic liver cancer who were good candidates for this treatment. The goal was to see if this approach could safely reduce radiation damage to healthy tissue.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER (PRIMARY AND METASTATIC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Seoul National University Hospital

    Seoul, 03080, South Korea

Conditions

Explore the condition pages connected to this study.